Key result
Higher NT-proBNP levels were associated with increased risk of all-cause mortality and both CVD and non-CVD deaths in chronic dialysis patients.
Why the study?
Does NT-proBNP predict non-cardiovascular and all-cause mortality in prevalent chronic dialysis patients?
Observational (n=1,310)
Does NT-proBNP predict non-cardiovascular and all-cause mortality in prevalent chronic dialysis patients?
Answers are grounded in this paper and cite their sources.
NT-proBNP is a significant predictor of both cardiovascular and non-cardiovascular mortality in chronic dialysis patients.
N-terminal-pro-B-type-natriuretic peptide (NT-proBNP) was a predictive marker of cardiovascular disease (CVD)-related death in chronic dialysis patients. NT-proBNP was also correlated with markers of inflammation, malnutrition and protein-energy wasting. We hypothesized whether NT-proBNP was also associated with non-CVD death in chronic dialysis patients. A prospective observational study for incidence of death in chronic dialysis patients was conducted. Prevalent chronic dialysis patients (n = 1310) were enrolled and followed for 24 months. One hundred forty-four deaths were recorded. Area under the curve using ROC analysis for NT-proBNP showed: all causes of death (0.761), CVD-related (0.750), infection and malignancy-related (0.702) and others and unknown (0.745). After adjusting for age, sex, hemodialysis vintage, cardiothoracic ratio, mean pre-dialysis systolic blood pressure, dry weight and basal kidney disease, the hazard ratios (95% confidence intervals) per 1-log NT-proBNP calculated using multivariate Cox analysis were: all causes of death, 3.83 (2.51-5.85); CVD-related, 4.30 (2.12-8.75); infection and malignancy-related, 2.41 (1.17-4.93); and others and unknown origin, 5.63 (2.57-12.37). NT-proBNP was significantly associated not only with CVD-relate but also with non-CVD-related deaths in this population of prevalent chronic dialysis patients.
No takes yet. Share an insight, caveat, or question.
Kawagoe et al. (2018) conducted an observational in Chronic hemodialysis (n=1,310). NT-proBNP was evaluated on All causes of death (HR 3.83, 95% CI 2.51-5.85). Higher NT-proBNP levels were associated with increased risk of all-cause mortality and both CVD and non-CVD deaths in chronic dialysis patients.
Synapse has enriched 10 related papers. Consider them for comparative context: